Health

Tianjin Tongrentang Group Partners with Online Pharmacy Giant 111, Inc.

SHANGHAI, Nov. 29, 2019 /PRNewswire/ -- In a partnership combining one of China's oldest names in pharmaceuticals with one of its newest, 111, Inc. (NASDAQ: YI)("111" or the "Company") is partnering with Tianjin Tongrentang Group. Co., Ltd. to deliver traditional Chinese medicine using big data a...

2019-11-29 20:00 7855

Concord Medical Schedules 2019 Annual Meeting of Shareholders

BEIJING, Nov. 28, 2019 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a specialty hospital management group and an operator of the network of radiotherapy and diagnostic imaging centers inChina, today announced that it will hold its 201...

2019-11-28 17:30 6400

VUNO Presents the Future of Medical AI Solutions at RSNA 2019

CHICAGO, Nov. 27, 2019 /PRNewswire/ -- VUNO Inc., a medical AI solution developer and a member company of the Born2Global Centre, will participate in  RSNA (Radiological Society ofNorth America) 2019 in Chicago, December 1-8. Booth: North Hall Level2, #11132.

2019-11-27 21:30 1764

Venturing into the future of healthcare with AI - SonoScape at Medica 2019

DUSSELDORF, Germany, Nov. 25, 2019 /PRNewswire/ -- SonoScape, as one of the leading providers of medical ultrasound and endoscopy solutions, presented its latest products and technologies in the world's largest medical event Medica: its first echoendoscope EG-UR5 (endoscopic ultrasound), a new 4-...

2019-11-25 20:28 1691

Initiation of a Phase 2 Multicenter Study of 18F-APN-1607, a Novel Diagnostic PET Imaging Tracer for the Characterization of Tau Burden in Alzheimer's Disease

TAIPEI, Nov. 21, 2019 /PRNewswire/ -- APRINOIA Therapeutics, Inc. announced today that it has initiated a Phase 2 multicenter, multinational study of18F -APN-1607 in the US for its lead tau positron emission tomography (PET) tracer in Alzheimer's Disease (AD). The study (NCT number: NCT04141150) w...

2019-11-21 23:00 1548

Seed Health Announces Research Partnership with Atmo Biosciences to Evaluate Impact of Probiotics With First Ingestible Gas Sensor Technology

First tech-enabled clinical trial will use new biomarkers to measure effect of Seed's Daily Synbiotic on gut microbiome after antibiotic use LOS ANGELES, Nov. 21, 2019 /PRNewswire/ -- Seed Health, a microbial sciences company, today announced a research partnership with digital health company, At...

2019-11-21 21:00 1304

AnaPath Services Acquires Envigo CRS S.A.U. in Barcelona to provide full services in non-clinical safety assessment for chemical and pharmaceutical industries

GENEVA, Nov. 21, 2019 /PRNewswire/ -- AnaPath Services GmbH, the Swiss CRO specialized in histopathology, has acquired legacy Envigo CRS S.A.U. a CRO for non-clinical safety assessment onNovember 5th, 2019. With this step Envigo CRS was renamed to AnaPath Research S.A.U. Furthermore JorgeZapate...

2019-11-21 17:32 1215

The 2nd East Tech West Forum Kicked off in Guangzhou's Nansha

GUANGZHOU, China, Nov. 21, 2019 /PRNewswire/ -- Over 300 most influential global industry leaders convened in the Nansha district ofGuangzhou, China from November 18 to 20 for the second East Tech West, a global forum organized by CNBC. Its focus is on the innovation and development of such indus...

2019-11-21 14:33 2126

Ascentage Pharma Breaks Ground on its Global Headquarters, R&D Center and Manufacturing Facility in the Suzhou Industrial Park

SUZHOU, China and ROCKVILLE, Md., Nov. 20, 2019 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally-focused, clinical-stage biotechnology company engaged in developing novel therapies, announced that the groundbreaking ceremony for the Company's global headquarters, R&D center, and manufacturi...

2019-11-21 11:30 1702

Two Prominent Researchers of WPI-MANA and University of Washington Discuss Development of Smart Polymers and Biomaterials

TSUKUBA, Japan, Nov. 20, 2019 /PRNewswire/ -- The International Center for Materials Nanoarchitectonics (WPI-MANA), a unit of the National Institute for Materials Science (NIMS), had a visit from Prof.Allan S. Hoffman from the University of Washington, a pioneer in smart polymers and biomaterials...

2019-11-20 14:00 958

Conversational AI leader announces OrbitaASSIST, a digitally reimagined voice-powered, AI-driven virtual health assistant proven to improve patient communication at the bedside

BOSTON and SYDNEY, Nov. 19, 2019 /PRNewswire/ -- Orbita, the provider of healthcare's most powerful conversational AI platform, announced today that it is now offering OrbitaASSIST, an award-winning, voice-enabled, AI-driven bedside virtual health assistant. This market-proven solution offers an...

2019-11-19 21:33 1775

Burning Rock Dx Launches Magnis BR to Innovate Total Process Automation for NGS Testing

ZHENGZHOU, Nov. 19, 2019 /PRNewswire/ -- Today, Agilent Technologies and Guangzhou Burning Rock Medical Laboratory Co., Ltd. ("Burning Rock Dx") jointly held a product launch event on Magnis BR, an automated next generation sequencing (NGS) library preparation system, to announce that Magnis BR i...

2019-11-19 21:00 1492

Edan to Highlight Its New Developments at MEDICA 2019

DUSSELDORF, Germany, Nov. 19, 2019 /PRNewswire/ -- Edan, a healthcare solutions provider, revealed their latest product series in its all five product lines, including Obstetrics and Gynecology, Patient Monitoring, In-Vitro Diagnostics, Diagnostic ECG, and Ultrasound, bringing a huge surprise to ...

2019-11-19 18:18 1284

ABL Bio Inc.- GenScript Biotech Corp Bispecific Antibody Strategic Partnership Agreement Ceremony

NANJING, China and SEOUL, South Korea, Nov. 18, 2019 /PRNewswire/ -- GenScript Biologics, a world leading bio-pharmaceutical CDMO company, announced today that it entered into an agreement with ABL Bio Inc., a South Korean biotech company dedicated to therapeutics for immuno-oncology and neurodeg...

2019-11-18 22:00 1624

Plant Nanny 2, the Self-care Water Consumption Reminding app Has Been Nominated for "Google Play Best of 2019" Launches Brand New Version 2.0

TAIPEI, Nov. 18, 2019 /PRNewswire/ -- About 70% of human body is composed of water. However, according to the Quench Survey, nearly 80% of working Americans say they don't drink enough water. Keeping hydrated is crucial for a person's health and well-being, but there is a substantial amount of pe...

2019-11-18 14:30 3885

Yili launches "Yili Future Intelligence and Health Valley" to promote health industry dev.

BEIJING, Nov. 17, 2019 /PRNewswire/ -- China's dairy giant Inner Mongolia Yili Industrial Group on Sunday launched the project of "Yili Future Intelligence and Health Valley" in Hohhot, capital of northChina's Inner Mongolia Autonomous Region, striving for boosting the health industry in the regi...

2019-11-18 12:05 1662

3SBio Selects Verseau's PSGL-1-targeted Antibody VTX-0811 as First Partnered Macrophage Checkpoint Modulator in Immuno-Oncology Collaboration

SHENYANG, China and BEDFORD Mass., Nov. 17, 2019 /PRNewswire/ -- 3SBio Inc. ("3SBio") (HKEX:1530) and Verseau Therapeutics, Inc.  ("Verseau") today announced the selection of VTX-0811, a monoclonal antibody targeting PSGL-1, as the first lice...

2019-11-18 08:30 4200

China Pharma Holdings, Inc. Reports Third Quarter 2019 Financial Results

HAIKOU CITY, China, Nov. 15, 2019 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based inChina, today announced financial results for the qu...

2019-11-15 21:00 6435

Viva Biotech Partnership Summit Successfully Launched in Shanghai

SHANGHAI, Nov. 15, 2019 /PRNewswire/ -- 2019 Viva Biotech Partnership Summit (the "Summit") was successfully launched on8 November 2019 in Pudong, Shanghai, themed "Innovation Partnership Growth". Founders from over 30 global innovative and biopharmaceutical companies incubated/ invested by Viva ...

2019-11-15 14:16 2319

I-Mab Biopharma Receives IND Approval from NMPA to Initiate Clinical Trials for its Anti-GM-CSF Monoclonal Antibody TJM2 in China

SHANGHAI, Nov. 14, 2019 /PRNewswire/ -- I-Mab Biopharma ("I-Mab"), a China and U.S.-based clinical-stage biopharmaceutical company exclusively focused on the discovery and development of novel or highly differentiated biologics in immuno-oncology and autoimmune diseases today announced that Natio...

2019-11-14 23:45 1154
1 ... 276277278279280